A new approach to the prevention of graft-versus-host disease using XomaZyme-H65 following histo-incompatible partially T-depleted marrow grafts.

Authors :: Henslee PJ
Byers VS
Jennings CD
Marciniak E
Thompson JS
Macdonald JS
Romond EH
Messino MJ
Scannon PJ
Source :: Transplantation proceedings [Transplant Proc] 1989 Feb; Vol. 21 (1 Pt 3), pp. 3004-7.
Publication Year :: 1989

Subjects :: Adult
Drug Evaluation
Graft vs Host Disease immunology
Histocompatibility Testing
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive immunology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive surgery
Leukemia, Myelogenous, Chronic, BCR-ABL Positive therapy
Male
Postoperative Complications prevention & control
Ricin immunology
Antibodies, Monoclonal therapeutic use
Bone Marrow Transplantation immunology
Graft vs Host Disease prevention & control
Immunotoxins therapeutic use
Lymphocyte Depletion
Ricin therapeutic use
T-Lymphocytes

Tools